Published in Anesthesiology on March 01, 2010
Depression, C-reactive protein and length of post-operative hospital stay in coronary artery bypass graft surgery patients. Brain Behav Immun (2013) 0.83
Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction? Front Cardiovasc Med (2016) 0.83
Increased preoperative C-reactive protein levels are associated with inhospital death after coronary artery bypass surgery. Inflammation (2012) 0.79
GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting. Anesthesiology (2014) 0.79
Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study. Eur J Cardiovasc Nurs (2013) 0.75
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med (1994) 8.10
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J (2008) 3.24
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem (2001) 3.12
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol (2005) 2.64
C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J (2006) 2.04
Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol (2001) 2.01
Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet (2005) 2.00
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1998) 1.96
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res (2005) 1.91
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg (2006) 1.78
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis (2002) 1.42
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation (2004) 1.32
Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J (2009) 1.20
Preoperative C-reactive protein predicts mid-term outcome after cardiac surgery. Ann Thorac Surg (2006) 1.03
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2006) 0.99
Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg (2006) 0.97
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg (2007) 0.88
Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol (1998) 0.82
Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology (2005) 2.81
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Vascular ischaemia and reperfusion injury. Br Med Bull (2004) 2.28
Utility of intraoperative transesophageal echocardiography for diagnosis of pulmonary embolism. Anesth Analg (2004) 2.26
Cardiac output monitoring using indicator-dilution techniques: basics, limits, and perspectives. Anesth Analg (2010) 2.23
Influence of genotype on perioperative risk and outcome. Anesthesiology (2003) 2.15
3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr (2007) 2.12
Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg (2008) 1.89
Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics (2009) 1.86
Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting. Anesthesiology (2009) 1.85
Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology (2006) 1.70
Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology (2006) 1.70
Safety of transesophageal echocardiography. J Am Soc Echocardiogr (2010) 1.67
Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J Thorac Cardiovasc Surg (2010) 1.60
Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2011) 1.60
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. Crit Care Med (2012) 1.58
Does rotational thromboelastometry (ROTEM) improve prediction of bleeding after cardiac surgery? Anesth Analg (2012) 1.58
Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth Analg (2010) 1.55
Case scenario: anesthetic considerations for thoracoabdominal aortic aneurysm repair. Anesthesiology (2011) 1.49
Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation. Ann Thorac Surg (2004) 1.49
Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet (2011) 1.48
Statin therapy within the perioperative period. Anesthesiology (2008) 1.47
The role of statins in cancer therapy. Oncologist (2006) 1.46
A practical approach to a comprehensive epicardial and epiaortic echocardiographic examination. J Cardiothorac Vasc Anesth (2003) 1.46
Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery. Anesth Analg (2006) 1.42
Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. Anesth Analg (2006) 1.41
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann Thorac Surg (2006) 1.39
Echocardiographic evaluation of mitral inflow hemodynamics after asymmetric double-orifice repair. Anesth Analg (2014) 1.39
Pro: Newly appreciated pathophysiology of ischemic heart disease in women mandates changes in perioperative management. Anesth Analg (2008) 1.39
The feasibility of epicardial echocardiography for measuring aortic valve area by the continuity equation. Anesth Analg (2009) 1.39
Late rupture of polytetrafluoroethylene neochordae after mitral valve repair. J Thorac Cardiovasc Surg (2008) 1.39
Case 6-2006. Percutaneous superior vena cava cannulation for repeat sternotomy in cardiac operations. J Cardiothorac Vasc Anesth (2006) 1.38
The Mechanism of Mitral Regurgitation Influences the Temporal Dynamics of the Vena Contracta Area as Measured with Color Flow Doppler. Anesth Analg (2016) 1.38
Perioperative statin therapy: are formal guidelines and physician education needed? Anesth Analg (2007) 1.38
Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements. Anesth Analg (2009) 1.38
Acute hemodynamic collapse after induction of general anesthesia for emergent pulmonary embolectomy. Anesth Analg (2006) 1.38
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med (2007) 1.35
Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg (2010) 1.34
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation (2004) 1.32
Live 3-dimensional transesophageal echocardiography initial experience using the fully-sampled matrix array probe. J Am Coll Cardiol (2008) 1.24
Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J (2009) 1.20
The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. J Extra Corpor Technol (2010) 1.19
A common genetic variant within SCN10A modulates cardiac SCN5A expression. J Clin Invest (2014) 1.17
Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr (2008) 1.14
The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North America (2003) 1.12
The influence of epiaortic ultrasonography on intraoperative surgical management in 6051 cardiac surgical patients. Ann Thorac Surg (2008) 1.11
Dynamic left ventricular inflow obstruction associated with a left atrial myxoma. Anesth Analg (2006) 1.08
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA (2004) 1.07
Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation (2010) 1.07
Left atrial dissection associated with pulmonary vein cannulation. Anesth Analg (2009) 1.06
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorac Cardiovasc Surg (2008) 1.06
A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg (2007) 1.05
Cancer classification and prediction using logistic regression with Bayesian gene selection. J Biomed Inform (2004) 1.02
Cardiac surgery in the parturient. Anesth Analg (2009) 1.02
The usefulness of transesophageal echocardiography during intraoperative cardiac arrest in noncardiac surgery. Anesth Analg (2006) 1.01
Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg (2004) 1.01
Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2006) 0.99
Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency. J Thorac Cardiovasc Surg (2009) 0.99
Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome. Anesthesiology (2015) 0.95